Innospec, Inc.

Innospec, Inc. has recently experienced a change in its evaluation score, reflecting a shift in its valuation grade. Key financial metrics include a P/E ratio of 15, a high dividend yield of 991.90%, and a return on capital employed of 14.89%. However, the company has faced challenges, including negative financial performance in recent quarters.

Innospec, Inc. has experienced a change in its valuation grade, now reflecting a fair standing. Key financial metrics include a P/E ratio of 15, a high dividend yield, and a decline in profits of 21.6% over the past year, alongside consistent underperformance against market benchmarks.

Innospec, Inc. has experienced a notable adjustment in its evaluation, with its valuation grade improving significantly. The company maintains competitive financial metrics, including a P/E ratio of 14 and a high dividend yield. Institutional holdings are strong at 100%, indicating robust investor confidence despite recent operational challenges.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation metrics, showing a P/E ratio of 14 and a notable dividend yield of 1051.30%. Despite competitive performance indicators, its stock returns have underperformed compared to the S&P 500 over the past year.

Innospec, Inc., a small-cap company in the Chemicals and Petrochemicals sector, has a P/E ratio of 14 and a notable dividend yield of 1051.30%. Its stock price recently closed at $76.26, reflecting a challenging year with a return of -14.77%, compared to the S&P 500's gain of 29.45%.

Innospec, Inc., a small-cap company in the Chemicals and Petrochemicals sector, has adjusted its valuation, showcasing a solid financial position with favorable P/E and price-to-book ratios. The company demonstrates strong operational performance and impressive returns for shareholders, positioning itself well against peers in the industry.

Innospec, Inc. has recently adjusted its valuation metrics, reporting a P/E ratio of 14 and a price-to-book value of 1.52. The company features a notable dividend yield of 1051.30% and a ROCE of 14.89%. Its stock performance has lagged behind the S&P 500 over the past year.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation. The firm has faced a challenging year with a notable decline in returns. Despite this, it maintains competitive financial metrics, including a high dividend yield and favorable P/E and EV to EBITDA ratios compared to industry peers.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. The company, with a market capitalization of USD 2,022 million, shows a high dividend yield and low debt levels, but has faced challenges including decreased net profit and operating cash flow.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,022 million, faces challenges including a net profit decline and low operating cash flow, despite a high dividend yield.

Innospec, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company maintains a market capitalization of USD 2,022 million and a high dividend yield. Despite profitability indicators, it faces difficulties with declining net profit and operating cash flow.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,411 million, faces challenges including a negative growth rate in net profit and low operating cash flow, despite a high dividend yield.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has experienced a challenging year with a significant decline in stock performance compared to the S&P 500. Current technical indicators suggest a bearish sentiment, reflecting the company's struggles in a competitive market environment.

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 2,411 million, shows a high dividend yield but struggles with growth, raising concerns about its competitive position in the market.

Innospec, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with the stock underperforming significantly over the past year and year-to-date, suggesting ongoing challenges in the market environment.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has experienced a recent price decline. Technical indicators present a mixed outlook, with some suggesting bullish trends while others indicate bearish signals. The company's performance has lagged behind the S&P 500, reflecting ongoing market challenges.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a 25.93% decline over the past year, this technical signal may suggest a possible recovery as the company navigates its market position.

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation metrics, showcasing a competitive price-to-earnings ratio of 13 and a high dividend yield of 915.95%. Its strong operational performance is reflected in a return on capital employed of 15.96% and return on equity of 13.44%.

Innospec, Inc. reported a mixed financial performance for the quarter ending December 2025, achieving a record dividend and solid operating profit, while facing challenges with declining operating cash flow and net profit. The company's stock has underperformed compared to broader market indices, highlighting operational hurdles.